S
0.922
0.02 (2.39%)
| Penutupan Terdahulu | 0.900 |
| Buka | 0.920 |
| Jumlah Dagangan | 123,637 |
| Purata Dagangan (3B) | 170,966 |
| Modal Pasaran | 12,086,763 |
| Harga / Pendapatan (P/E TTM) | 1.40 |
| Harga / Pendapatan (P/E Ke hadapan) | 21.83 |
| Harga / Jualan (P/S) | 37.21 |
| Harga / Buku (P/B) | 0.160 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 Aug 2025 - 11 Aug 2025 |
| Hasil Dividen (DY TTM) | 162.78% |
| Margin Operasi (TTM) | -34,814.94% |
| EPS Cair (TTM) | 0.660 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -58.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.70% |
| Nisbah Semasa (MRQ) | 1.05 |
| Aliran Tunai Operasi (OCF TTM) | -7.03 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -6.06 M |
| Pulangan Atas Aset (ROA TTM) | -14.99% |
| Pulangan Atas Ekuiti (ROE TTM) | -35.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Pharmaceutical Retailers (US) | Bercampur | Bercampur |
| Pharmaceutical Retailers (Global) | Menurun | Bercampur | |
| Stok | Scienture Holdings, Inc. | - | - |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.00 |
|
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S. |
|
| Sektor | Healthcare |
| Industri | Pharmaceutical Retailers |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 32.59% |
| % Dimiliki oleh Institusi | 1.35% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 17 Jun 2025 | Pengumuman | Scienture Holdings Announces Cancelation of ELOC |
| 22 May 2025 | Pengumuman | SCIENTURE Announces Executive Leadership Transition |
| 19 May 2025 | Pengumuman | SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. |
| 22 Apr 2025 | Pengumuman | SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025. |
| 08 Apr 2025 | Pengumuman | SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC. |
| 03 Apr 2025 | Pengumuman | Scienture Holdings, Inc. Issues Annual Letter to Shareholders |
| Hasil Dividen (DY TTM) | 162.78% |
| Purata Hasil Dividen 1T | 157.03% |
| Jangkaan Pembayaran Dividen Seterusnya | Jul 2025 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 19 Jul 2024 | 08 Jul 2024 | 24 Jul 2024 | 1.5 Tunai |
| 25 Mar 2024 | 28 Feb 2024 | 22 Mar 2024 | 8 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2024 | 9.50 | 2 | 157.03 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |